Inovio Pharmaceuticals, Inc. (INO) Financial Statements (2024 and earlier)

Company Profile

Business Address 6769 MESA RIDGE RD.
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:253,000401,300411,60089,50081,200127,425
Cash and cash equivalents46,32971,144250,72822,19623,69423,787
Short-term investments206,669330,171160,91567,33857,539103,639
Other undisclosed cash, cash equivalents, and short-term investments1(15)(43)(34)(32) 
Receivables 11,7388,03219,0642,0324,0556,490
Prepaid expense18,72911,3634,696   
Other undisclosed current assets31,77527,75035,8112,6692,5604,447
Total current assets:315,243448,445471,17194,20187,815138,362
Noncurrent Assets
Operating lease, right-of-use asset10,22811,57112,74113,783
Property, plant and equipment7,72817,45311,34812,77315,94918,320
Long-term investments and receivables   434 9,4009,069
Long-term investments   434 9,4009,069
Intangible assets, net (including goodwill) 12,64313,14013,66014,20715,27416,523
Goodwill 10,51310,51310,51310,51310,51310,513
Intangible assets, net (excluding goodwill) 2,1302,6263,1473,6944,7606,010
Other noncurrent assets6841,42625,9572,6722,6702,639
Other undisclosed noncurrent assets2,0073,9074,4606,31562,325
Total noncurrent assets:33,29147,49768,60249,75143,29848,877
TOTAL ASSETS:348,533495,941539,772143,952131,113187,239
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 79,68747,64521,20418,23723,13523,279
Employee-related liabilities16,11313,1278,9689,4677,997
Accrued liabilities 12,575   5,6728,612
Other undisclosed accounts payable and accrued liabilities 67,11231,5328,0779,2697,9966,670
Deferred revenue  224792
Debt   2,075  
Deferred rent credit     1,065
Deferred revenue and credits2,053
Due to related parties1,220548643730978927
Contract with customer, liability224
Other undisclosed current liabilities15,96117,52719,81310,8559,8989,147
Total current liabilities:96,86865,74241,70631,98935,30035,405
Noncurrent Liabilities
Long-term debt and lease obligation:  15,46018,06420,410  
Liabilities, other than long-term debt12,6881111698,9908,7569,320
Deferred revenue and credits9,320
Deferred revenue  6479102
Contract with customer, liability151
Deferred rent credit     8,518
Deferred income tax liabilities32323232
Other liabilities  15583787 
Operating lease, liability12,65615,46018,06420,410
Derivative instruments and hedges, liabilities    8,819  
Other undisclosed noncurrent liabilities 16,61514,96018,69377,1582525
Total noncurrent liabilities:29,30230,53036,926106,5578,7819,345
Total liabilities:126,17196,27278,632138,54744,08144,750
Equity
Equity, attributable to parent222,363399,669461,1413,43586,936142,393
Common stock2532171871019790
Additional paid in capital1,710,6561,609,5901,367,407742,647707,794665,776
Accumulated other comprehensive income (loss)(699)(282)(256)473(529)(117)
Accumulated deficit(1,487,848)(1,209,856)(906,197)(739,786)(620,426)(523,356)
Equity, attributable to noncontrolling interest    1,9709696
Total equity:222,363399,669461,1415,40587,032142,489
TOTAL LIABILITIES AND EQUITY:348,533495,941539,772143,952131,113187,239

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues10,2623,3637,4114,11230,48242,220
Revenue, net42,220
Net investment income4,7823,3633,3122,606  
Gross profit:10,2623,3637,4114,11230,48242,220
Operating expenses(277,836)(302,993)(131,493)(115,220)(124,573)(125,863)
Other undisclosed operating loss (1,588)    
Operating loss:(267,574)(301,218)(124,082)(111,109)(94,091)(83,643)
Nonoperating income (expense)(3,862)3433,416496  
Investment income, nonoperating   4,121   
Other nonoperating income (expense)(3,862)343(705)496  
Interest and debt expense(1,254)(1,936)(8,702)(7,949)  
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(4,964)     
Loss from continuing operations before equity method investments, income taxes:(277,653)(302,811)(129,368)(118,561)(94,091)(83,643)
Loss from equity method investments (2,165)     
Other undisclosed income (loss) from continuing operations before income taxes2,166(413)(33,522)(2,248)(707)(4,563)
Loss from continuing operations before income taxes:(277,652)(303,224)(162,890)(120,809)(94,798)(88,206)
Income tax expense (benefit)    257(2,170) 
Loss from continuing operations:(277,652)(303,224)(162,890)(120,552)(96,968)(88,206)
Loss before gain (loss) on sale of properties:(303,224)(162,890)(120,552)(96,968)(88,206)
Other undisclosed net loss(2,166)(434)(4,585)   
Net loss:(279,818)(303,659)(167,475)(120,552)(96,968)(88,206)
Net income attributable to noncontrolling interest   1,0641,193  
Net loss attributable to parent:(279,818)(303,659)(166,411)(119,359)(96,968)(88,206)
Other undisclosed net loss available to common stockholders, basic      (807)
Net loss available to common stockholders, diluted:(279,818)(303,659)(166,411)(119,359)(96,968)(89,013)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(279,818)(303,659)(167,475)(120,552)(96,968)(88,206)
Other comprehensive income    266  
Other undisclosed comprehensive income (loss)(417)(26)(729)735(180)(1,445)
Comprehensive loss:(280,235)(303,685)(168,204)(119,550)(97,148)(89,651)
Comprehensive income, net of tax, attributable to noncontrolling interest   1,0641,193  
Comprehensive loss, net of tax, attributable to parent:(280,235)(303,685)(167,140)(118,358)(97,148)(89,651)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: